The design of an acceptable medicine is a critical step for ensuring treatment success. Acceptability of medicine aims to prevent poor compliance and unlicensed use, especially in pediatric and geriatric populations.
Over the last few years, ClinSearch has acquired valuable knowledge of predictive factors of acceptability, discovered and extracted from a large database of medicines’ evaluations. Based on valid, useful, and understandable information, our consulting services can support you in designing a highly acceptable medicine.
In addition, we can provide you with a relevant acceptability assessment of your medicine using CAST- ClinSearch Acceptability Score Test®, which is pending classification as a novel acceptability methodology by the EMA.
Our data mining model uses real-life objective measures to position your medicine on the acceptability map and to characterize it by an acceptability profile. This service provides you with standardized comparisons of great value among global market products.
ClinSearch will be presenting CAST at the following events in 2017:
9th Conference of the European Paediatric Formulation Initiative
September 21-22, Warsaw, Poland
37th Congress of the French Society for Geriatric Medicine and Gerontology
November 27-29, Paris, France